nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Rivaroxaban—ABCB1—peripheral nervous system neoplasm	0.0136	1	CrCbGaD
Linezolid—MAOB—nerve—peripheral nervous system neoplasm	0.00404	0.151	CbGeAlD
Linezolid—MAOB—ganglion—peripheral nervous system neoplasm	0.00399	0.149	CbGeAlD
Linezolid—MAOA—nerve—peripheral nervous system neoplasm	0.00345	0.129	CbGeAlD
Linezolid—MAOA—ganglion—peripheral nervous system neoplasm	0.0034	0.127	CbGeAlD
Linezolid—MAOB—trigeminal ganglion—peripheral nervous system neoplasm	0.00196	0.0733	CbGeAlD
Linezolid—MAOB—parotid gland—peripheral nervous system neoplasm	0.00185	0.0692	CbGeAlD
Linezolid—MAOB—brainstem—peripheral nervous system neoplasm	0.00173	0.0649	CbGeAlD
Linezolid—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.00167	0.0626	CbGeAlD
Linezolid—MAOA—parotid gland—peripheral nervous system neoplasm	0.00158	0.059	CbGeAlD
Linezolid—MAOA—brainstem—peripheral nervous system neoplasm	0.00148	0.0554	CbGeAlD
Linezolid—MAOB—cerebellum—peripheral nervous system neoplasm	0.000855	0.032	CbGeAlD
Linezolid—MAOA—cerebellum—peripheral nervous system neoplasm	0.000729	0.0273	CbGeAlD
Linezolid—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000724	0.000754	CcSEcCtD
Linezolid—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000722	0.000752	CcSEcCtD
Linezolid—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000721	0.000752	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000751	CcSEcCtD
Linezolid—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00072	0.00075	CcSEcCtD
Linezolid—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000716	0.000746	CcSEcCtD
Linezolid—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000714	0.000744	CcSEcCtD
Linezolid—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000713	0.000743	CcSEcCtD
Linezolid—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000712	0.000742	CcSEcCtD
Linezolid—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000706	0.000736	CcSEcCtD
Linezolid—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000706	0.000736	CcSEcCtD
Linezolid—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000706	0.000735	CcSEcCtD
Linezolid—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000704	0.000733	CcSEcCtD
Linezolid—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.0007	0.00073	CcSEcCtD
Linezolid—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000699	0.000728	CcSEcCtD
Linezolid—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.000727	CcSEcCtD
Linezolid—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000696	0.000725	CcSEcCtD
Linezolid—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000693	0.000722	CcSEcCtD
Linezolid—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000692	0.000721	CcSEcCtD
Linezolid—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000692	0.000721	CcSEcCtD
Linezolid—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00069	0.000719	CcSEcCtD
Linezolid—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00069	0.000719	CcSEcCtD
Linezolid—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00069	0.000719	CcSEcCtD
Linezolid—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000685	0.000713	CcSEcCtD
Linezolid—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000712	CcSEcCtD
Linezolid—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000679	0.000708	CcSEcCtD
Linezolid—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000679	0.000708	CcSEcCtD
Linezolid—Rash—Topotecan—peripheral nervous system neoplasm	0.000679	0.000708	CcSEcCtD
Linezolid—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000678	0.000707	CcSEcCtD
Linezolid—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000678	0.000707	CcSEcCtD
Linezolid—Cough—Etoposide—peripheral nervous system neoplasm	0.000676	0.000704	CcSEcCtD
Linezolid—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000675	0.000704	CcSEcCtD
Linezolid—Headache—Topotecan—peripheral nervous system neoplasm	0.000675	0.000703	CcSEcCtD
Linezolid—Rash—Tretinoin—peripheral nervous system neoplasm	0.000674	0.000702	CcSEcCtD
Linezolid—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000674	0.000702	CcSEcCtD
Linezolid—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000673	0.000702	CcSEcCtD
Linezolid—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000673	0.000701	CcSEcCtD
Linezolid—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000673	0.000701	CcSEcCtD
Linezolid—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000673	0.000701	CcSEcCtD
Linezolid—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000671	0.000699	CcSEcCtD
Linezolid—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00067	0.000699	CcSEcCtD
Linezolid—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00067	0.000698	CcSEcCtD
Linezolid—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.000698	CcSEcCtD
Linezolid—Headache—Tretinoin—peripheral nervous system neoplasm	0.000669	0.000697	CcSEcCtD
Linezolid—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000669	0.000697	CcSEcCtD
Linezolid—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000668	0.000697	CcSEcCtD
Linezolid—Pain—Vincristine—peripheral nervous system neoplasm	0.000667	0.000695	CcSEcCtD
Linezolid—Constipation—Vincristine—peripheral nervous system neoplasm	0.000667	0.000695	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000695	CcSEcCtD
Linezolid—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000667	0.000695	CcSEcCtD
Linezolid—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000665	0.000693	CcSEcCtD
Linezolid—Rash—Melphalan—peripheral nervous system neoplasm	0.000665	0.000693	CcSEcCtD
Linezolid—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000664	0.000692	CcSEcCtD
Linezolid—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000662	0.00069	CcSEcCtD
Linezolid—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000658	0.000685	CcSEcCtD
Linezolid—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000656	0.000683	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000649	0.000676	CcSEcCtD
Linezolid—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.00067	CcSEcCtD
Linezolid—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00064	0.000667	CcSEcCtD
Linezolid—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00064	0.000667	CcSEcCtD
Linezolid—Nausea—Topotecan—peripheral nervous system neoplasm	0.00064	0.000667	CcSEcCtD
Linezolid—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000638	0.000665	CcSEcCtD
Linezolid—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000665	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000636	0.000662	CcSEcCtD
Linezolid—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000635	0.000661	CcSEcCtD
Linezolid—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000635	0.000661	CcSEcCtD
Linezolid—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000632	0.000659	CcSEcCtD
Linezolid—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000626	0.000653	CcSEcCtD
Linezolid—Nausea—Melphalan—peripheral nervous system neoplasm	0.000626	0.000653	CcSEcCtD
Linezolid—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000619	0.000645	CcSEcCtD
Linezolid—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000619	0.000645	CcSEcCtD
Linezolid—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000643	CcSEcCtD
Linezolid—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000617	0.000643	CcSEcCtD
Linezolid—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000617	0.000643	CcSEcCtD
Linezolid—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.000642	CcSEcCtD
Linezolid—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000615	0.000641	CcSEcCtD
Linezolid—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000614	0.00064	CcSEcCtD
Linezolid—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000611	0.000637	CcSEcCtD
Linezolid—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000611	0.000636	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000607	0.000632	CcSEcCtD
Linezolid—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000602	0.000628	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000626	CcSEcCtD
Linezolid—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.0006	0.000625	CcSEcCtD
Linezolid—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000597	0.000623	CcSEcCtD
Linezolid—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000596	0.000621	CcSEcCtD
Linezolid—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000592	0.000616	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000615	CcSEcCtD
Linezolid—Pain—Cisplatin—peripheral nervous system neoplasm	0.00059	0.000615	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000613	CcSEcCtD
Linezolid—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000607	CcSEcCtD
Linezolid—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.000605	CcSEcCtD
Linezolid—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000603	CcSEcCtD
Linezolid—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000573	0.000597	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000595	CcSEcCtD
Linezolid—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000567	0.000591	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000589	CcSEcCtD
Linezolid—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000563	0.000587	CcSEcCtD
Linezolid—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000586	CcSEcCtD
Linezolid—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000562	0.000585	CcSEcCtD
Linezolid—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00056	0.000583	CcSEcCtD
Linezolid—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000559	0.000582	CcSEcCtD
Linezolid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000555	0.000578	CcSEcCtD
Linezolid—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.000577	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000574	CcSEcCtD
Linezolid—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000551	0.000574	CcSEcCtD
Linezolid—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000549	0.000572	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.00057	CcSEcCtD
Linezolid—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000569	CcSEcCtD
Linezolid—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000546	0.000569	CcSEcCtD
Linezolid—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000545	0.000568	CcSEcCtD
Linezolid—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000545	0.000568	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000544	0.000567	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000564	CcSEcCtD
Linezolid—Constipation—Etoposide—peripheral nervous system neoplasm	0.00054	0.000563	CcSEcCtD
Linezolid—Pain—Etoposide—peripheral nervous system neoplasm	0.00054	0.000563	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000562	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000558	CcSEcCtD
Linezolid—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.000558	CcSEcCtD
Linezolid—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000534	0.000556	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000542	CcSEcCtD
Linezolid—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000519	0.00054	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000539	CcSEcCtD
Linezolid—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000517	0.000538	CcSEcCtD
Linezolid—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000516	0.000538	CcSEcCtD
Linezolid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.000536	CcSEcCtD
Linezolid—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.000532	CcSEcCtD
Linezolid—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.000531	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000531	CcSEcCtD
Linezolid—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000507	0.000528	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000526	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000525	CcSEcCtD
Linezolid—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000502	0.000523	CcSEcCtD
Linezolid—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000522	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000522	CcSEcCtD
Linezolid—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.0005	0.000521	CcSEcCtD
Linezolid—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0005	0.000521	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000499	0.00052	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000517	CcSEcCtD
Linezolid—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000496	0.000517	CcSEcCtD
Linezolid—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000495	0.000516	CcSEcCtD
Linezolid—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000516	CcSEcCtD
Linezolid—Rash—Vincristine—peripheral nervous system neoplasm	0.000492	0.000513	CcSEcCtD
Linezolid—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000491	0.000512	CcSEcCtD
Linezolid—Headache—Vincristine—peripheral nervous system neoplasm	0.000489	0.000509	CcSEcCtD
Linezolid—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.000501	CcSEcCtD
Linezolid—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000472	0.000492	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000491	CcSEcCtD
Linezolid—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000484	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000483	CcSEcCtD
Linezolid—Nausea—Vincristine—peripheral nervous system neoplasm	0.000463	0.000483	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000481	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000478	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000477	CcSEcCtD
Linezolid—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000453	0.000472	CcSEcCtD
Linezolid—Chills—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000466	CcSEcCtD
Linezolid—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000447	0.000466	CcSEcCtD
Linezolid—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000439	0.000457	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000455	CcSEcCtD
Linezolid—Rash—Cisplatin—peripheral nervous system neoplasm	0.000435	0.000453	CcSEcCtD
Linezolid—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000435	0.000453	CcSEcCtD
Linezolid—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000452	CcSEcCtD
Linezolid—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000432	0.000451	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000448	CcSEcCtD
Linezolid—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000446	CcSEcCtD
Linezolid—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000443	CcSEcCtD
Linezolid—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000418	0.000435	CcSEcCtD
Linezolid—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000435	CcSEcCtD
Linezolid—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000431	CcSEcCtD
Linezolid—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00041	0.000427	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000426	CcSEcCtD
Linezolid—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000402	0.000419	CcSEcCtD
Linezolid—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000418	CcSEcCtD
Linezolid—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000418	CcSEcCtD
Linezolid—Rash—Etoposide—peripheral nervous system neoplasm	0.000398	0.000415	CcSEcCtD
Linezolid—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000398	0.000415	CcSEcCtD
Linezolid—Headache—Etoposide—peripheral nervous system neoplasm	0.000396	0.000413	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000412	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.00041	CcSEcCtD
Linezolid—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000406	CcSEcCtD
Linezolid—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000405	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000402	CcSEcCtD
Linezolid—Cough—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000395	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000394	CcSEcCtD
Linezolid—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000392	CcSEcCtD
Linezolid—Nausea—Etoposide—peripheral nervous system neoplasm	0.000375	0.000391	CcSEcCtD
Linezolid—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000375	0.00039	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000387	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000377	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000376	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000375	CcSEcCtD
Linezolid—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000369	CcSEcCtD
Linezolid—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000365	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000363	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000361	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000361	CcSEcCtD
Linezolid—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000359	CcSEcCtD
Linezolid—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000357	CcSEcCtD
Linezolid—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000352	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000348	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000342	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000334	CcSEcCtD
Linezolid—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000334	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000332	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000331	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00033	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000329	CcSEcCtD
Linezolid—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000328	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000326	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000325	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000321	CcSEcCtD
Linezolid—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000319	CcSEcCtD
Linezolid—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000318	CcSEcCtD
Linezolid—Pain—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000316	CcSEcCtD
Linezolid—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000316	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000309	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000307	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000304	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000304	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000302	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000301	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000297	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000295	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000294	CcSEcCtD
Linezolid—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000293	CcSEcCtD
Linezolid—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000292	CcSEcCtD
Linezolid—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000292	CcSEcCtD
Linezolid—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000292	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000292	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000279	CcSEcCtD
Linezolid—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000271	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00027	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00027	CcSEcCtD
Linezolid—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000265	CcSEcCtD
Linezolid—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000261	CcSEcCtD
Linezolid—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000253	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000245	CcSEcCtD
Linezolid—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000244	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000242	CcSEcCtD
Linezolid—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000235	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000234	CcSEcCtD
Linezolid—Rash—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000233	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000233	CcSEcCtD
Linezolid—Headache—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000231	CcSEcCtD
Linezolid—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000226	CcSEcCtD
Linezolid—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000219	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000217	CcSEcCtD
Linezolid—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000215	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000215	CcSEcCtD
Linezolid—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000214	CcSEcCtD
Linezolid—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000203	CcSEcCtD
